Importance of the Amino Terminus in Secretin Family G Protein-coupled Receptors
暂无分享,去创建一个
[1] T. Lybrand,et al. Spatial Approximation between Two Residues in the Mid-region of Secretin and the Amino Terminus of Its Receptor , 2003, Journal of Biological Chemistry.
[2] A. Couvineau,et al. Photoaffinity Labeling Demonstrates Physical Contact between Vasoactive Intestinal Peptide and the N-terminal Ectodomain of the Human VPAC1 Receptor* , 2003, Journal of Biological Chemistry.
[3] T. Lybrand,et al. Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor. , 2003, Molecular pharmacology.
[4] L. Miller,et al. Development of a biologically active secretin analogue incorporating a radioiodinatable photolabile p-(4-hydroxybenzoyl)phenylalanine in position 10 , 2002, Regulatory Peptides.
[5] T. Lybrand,et al. Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus. , 2002, Molecular endocrinology.
[6] R. Rudolph,et al. In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor. , 2002, Biophysical chemistry.
[7] L. Miller,et al. Molecular pharmacology of the secretin receptor. , 2002, Receptors & channels.
[8] P. Sexton,et al. Molecular pharmacology of the calcitonin receptor. , 2002, Receptors & channels.
[9] H. Jüppner,et al. Identification of Determinants of Inverse Agonism in a Constitutively Active Parathyroid Hormone/Parathyroid Hormone-related Peptide Receptor by Photoaffinity Cross-linking and Mutational Analysis* , 2001, The Journal of Biological Chemistry.
[10] L. Miller,et al. Identification of Peptide Ligand-binding Domains within the Human Motilin Receptor Using Photoaffinity Labeling* , 2001, The Journal of Biological Chemistry.
[11] W. Fischer,et al. Expression, Purification, and Characterization of a Soluble Form of the First Extracellular Domain of the Human Type 1 Corticotropin Releasing Factor Receptor* , 2001, The Journal of Biological Chemistry.
[12] H. Jüppner,et al. Multiple Sites of Contact between the Carboxyl-terminal Binding Domain of PTHrP-(1–36) Analogs and the Amino-terminal Extracellular Domain of the PTH/PTHrP Receptor Identified by Photoaffinity Cross-linking* , 2001, Journal of Biological Chemistry.
[13] T. Lybrand,et al. Refinement of the Structure of the Ligand-occupied Cholecystokinin Receptor Using a Photolabile Amino-terminal Probe* , 2001, The Journal of Biological Chemistry.
[14] M. Pondel,et al. Calcitonin and calcitonin receptors: bone and beyond , 2000, International journal of experimental pathology.
[15] Y. Asmann,et al. Structural insights into the amino-terminus of the secretin receptor: I. Status of cysteine and cystine residues. , 2000, Molecular pharmacology.
[16] Y. Asmann,et al. Identification of Two Pairs of Spatially Approximated Residues within the Carboxyl Terminus of Secretin and Its Receptor* , 2000, The Journal of Biological Chemistry.
[17] R. Rudolph,et al. The N-terminal fragment of human parathyroid hormone receptor 1 constitutes a hormone binding domain and reveals a distinct disulfide pattern. , 2000, Biochemistry.
[18] M. Chorev,et al. Mapping the bimolecular interface of the parathyroid hormone (PTH)-PTH1 receptor complex: spatial proximity between Lys(27) (of the hormone principal binding domain) and leu(261) (of the first extracellular loop) of the human PTH1 receptor. , 2000, Biochemistry.
[19] G. Bitan,et al. Photoaffinity Cross-linking Identifies Differences in the Interactions of an Agonist and an Antagonist with the Parathyroid Hormone/Parathyroid Hormone-related Protein Receptor* , 2000, The Journal of Biological Chemistry.
[20] L. Miller,et al. Identification of an Interaction between Residue 6 of the Natural Peptide Ligand and a Distinct Residue within the Amino-terminal Tail of the Secretin Receptor* , 1999, The Journal of Biological Chemistry.
[21] L. Miller,et al. Demonstration of a Direct Interaction between Residue 22 in the Carboxyl-terminal Half of Secretin and the Amino-terminal Tail of the Secretin Receptor Using Photoaffinity Labeling* , 1999, The Journal of Biological Chemistry.
[22] L. Miller,et al. Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis. , 1998, The Journal of pharmacology and experimental therapeutics.
[23] H. Jüppner,et al. Evidence for a Ligand Interaction Site at the Amino-Terminus of the Parathyroid Hormone (PTH)/PTH-related Protein Receptor from Cross-linking and Mutational Studies* , 1998, The Journal of Biological Chemistry.
[24] T. Lybrand,et al. Direct Identification of a Second Distinct Site of Contact between Cholecystokinin and Its Receptor* , 1998, The Journal of Biological Chemistry.
[25] L. Suva,et al. Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor. , 1997, The Journal of pharmacology and experimental therapeutics.
[26] T. Lybrand,et al. Direct Identification of a Distinct Site of Interaction between the Carboxyl-terminal Residue of Cholecystokinin and the Type A Cholecystokinin Receptor Using Photoaffinity Labeling* , 1997, The Journal of Biological Chemistry.
[27] L. Suva,et al. Direct mapping of an agonist-binding domain within the parathyroid hormone/parathyroid hormone-related protein receptor by photoaffinity crosslinking. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[28] P. Sexton,et al. Structure/function relationships of calcitonin analogues as agonists, antagonists, or inverse agonists in a constitutively activated receptor cell system. , 1997, Molecular pharmacology.
[29] J. Vilardaga,et al. The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors , 1996, Peptides.
[30] S. Goldring,et al. Full Activation of Chimeric Receptors by Hybrids between Parathyroid Hormone and Calcitonin , 1996, The Journal of Biological Chemistry.
[31] J. Bockaert,et al. Alternative Splicing in the N-terminal Extracellular Domain of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Receptor Modulates Receptor Selectivity and Relative Potencies of PACAP-27 and PACAP-38 in Phospholipase C Activation* , 1996, The Journal of Biological Chemistry.
[32] L. Miller,et al. Relationship Between Native and Recombinant Cholecystokinin Receptors: Role of Differential Glycosylation , 1996, Pancreas.
[33] J. Vilardaga,et al. Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor. , 1996, European journal of biochemistry.
[34] L. Miller,et al. Multiple Extracellular Loop Domains Contribute Critical Determinants for Agonist Binding and Activation of the Secretin Receptor* , 1996, The Journal of Biological Chemistry.
[35] Y. Cao,et al. The amino-terminal fragment of the adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain. , 1995, Biochemical and biophysical research communications.
[36] J. Vilardaga,et al. Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination. , 1995, Biochemical and biophysical research communications.
[37] L. Miller,et al. Critical Contributions of Amino-terminal Extracellular Domains in Agonist Binding and Activation of Secretin and Vasoactive Intestinal Polypeptide Receptors. STUDIES OF CHIMERIC RECEPTORS (*) , 1995, The Journal of Biological Chemistry.
[38] T. Serwold,et al. Chimeric human calcitonin and glucagon receptors reveal two dissociable calcitonin interaction sites. , 1995, Biochemistry.
[39] F. Cardinaux,et al. N-terminal truncation of salmon calcitonin leads to calcitonin antagonists. Structure activity relationship of N-terminally truncated salmon calcitonin fragments in vitro and in vivo. , 1992, Biochemical and biophysical research communications.
[40] L. Miller,et al. Use of N,O-bis-Fmoc-D-Tyr-ONSu for introduction of an oxidative iodination site into cholecystokinin family peptides. , 2009, International journal of peptide and protein research.
[41] T. Martin,et al. Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications. , 1988, Endocrinology.
[42] L. Miller,et al. Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor. , 1987, The Journal of biological chemistry.
[43] T. Martin,et al. Photoaffinity labeling of the calcitonin receptor. , 1987, Pharmacology & therapeutics.
[44] T. Martin,et al. Identification of the calcitonin receptor by chemical cross‐linking and photoaffinity labeling in human cancer cell lines , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[45] G. Milhaud,et al. Purification and characterization of calcitonin receptors in rat kidney membranes by covalent cross-linking techniques. , 1986, European journal of biochemistry.
[46] E. Kaiser,et al. Amphiphilic secondary structure: design of peptide hormones. , 1984, Science.
[47] T. Martin,et al. Covalent cross-linking of a photoactive derivative of calcitonin to human breast cancer cell receptors. , 1982, The Journal of biological chemistry.
[48] D Rodbard,et al. Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.
[49] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[50] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.